Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

doi:10.3389/fonc.2020.01448

Comment

. 2020 Aug 19:10:1448.

doi: 10.3389/fonc.2020.01448. eCollection 2020.

Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Alexandra Lindsey Zune Djomkam^{1

2}, Charles Ochieng' Olwal^{1

2}, Theodore Beyeme Sala³, Lily Paemka^{1

2}

Affiliations

¹ West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra, Ghana.
² Department of Biochemistry, Cell and Molecular Biology, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.
³ Department of Urology, Laquintinie Hospital, Douala, Cameroon.

PMID: 32974166
PMCID: PMC7466403
DOI: 10.3389/fonc.2020.01448

Comment

Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Alexandra Lindsey Zune Djomkam et al. Front Oncol. 2020.

. 2020 Aug 19:10:1448.

doi: 10.3389/fonc.2020.01448. eCollection 2020.

Authors

Alexandra Lindsey Zune Djomkam^{1

2}, Charles Ochieng' Olwal^{1

2}, Theodore Beyeme Sala³, Lily Paemka^{1

2}

Affiliations

¹ West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra, Ghana.
² Department of Biochemistry, Cell and Molecular Biology, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.
³ Department of Urology, Laquintinie Hospital, Douala, Cameroon.

PMID: 32974166
PMCID: PMC7466403
DOI: 10.3389/fonc.2020.01448

No abstract available

Keywords: ACE2; COVID-19; SARS-CoV-2; TMPRSS2; coronavirus; prostate cancer.

PubMed Disclaimer

Comment on

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S. Hoffmann M, et al. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5. Cell. 2020. PMID: 32142651 Free PMC article.

Cited by

The impact of hypertension on clinical manifestations of Omicron variant BA.1 infection in adult patients.
Wang J, Dong H, Zhao J, Zhou C, Wang M, Cui Y, Gao G, Ji X, Mu H, Peng L. Wang J, et al. Microbiol Spectr. 2024 Jun 4;12(6):e0416823. doi: 10.1128/spectrum.04168-23. Epub 2024 Apr 26. Microbiol Spectr. 2024. PMID: 38666774 Free PMC article.
Antibiotics daptomycin interacts with S protein of SARS-CoV-2 to promote cell invasion of Omicron (B1.1.529) pseudovirus.
Cao X, Huang L, Tang M, Liang Y, Liu X, Hou H, Liang S. Cao X, et al. Virulence. 2024 Dec;15(1):2339703. doi: 10.1080/21505594.2024.2339703. Epub 2024 Apr 24. Virulence. 2024. PMID: 38576396 Free PMC article.
Novel mechanism of the COVID-19 associated coagulopathy (CAC) and vascular thromboembolism.
Singh M, Pushpakumar S, Zheng Y, Smolenkova I, Akinterinwa OE, Luulay B, Tyagi SC. Singh M, et al. Npj Viruses. 2023;1:3. doi: 10.1038/s44298-023-00003-3. Epub 2023 Oct 18. Npj Viruses. 2023. PMID: 38077924 Free PMC article.
Explanatory predictive model for COVID-19 severity risk employing machine learning, shapley addition, and LIME.
Laatifi M, Douzi S, Ezzine H, Asry CE, Naya A, Bouklouze A, Zaid Y, Naciri M. Laatifi M, et al. Sci Rep. 2023 Apr 4;13(1):5481. doi: 10.1038/s41598-023-31542-7. Sci Rep. 2023. PMID: 37015978 Free PMC article.
Delta Variant: Partially Sensitive To Vaccination, but Still Worth Global Attention.
Zhang M, He Y, Jie Z. Zhang M, et al. J Transl Int Med. 2022 Sep 24;10(3):227-235. doi: 10.2478/jtim-2022-0026. eCollection 2022 Sep. J Transl Int Med. 2022. PMID: 36776232 Free PMC article.

See all "Cited by" articles

References

1. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. (2020) 181:271–80. 10.1016/j.cell.2020.02.052 - DOI - PMC - PubMed
1. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. (2020) 367:1444–8. 10.1126/science.abb2762 - DOI - PMC - PubMed
1. Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W, et al. . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. (2020) 579:270–3. 10.1038/s41586-020-2012-7 - DOI - PMC - PubMed
1. Cheng H, Wang Y, Wang G. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. J Med Microbiol. (2020) 2020:1–5. 10.1002/jmv.25785 - DOI - PMC - PubMed
1. Sama I, Ravera A, Santema B, Goor H, Maaten J, Cleland J, et al. . Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. (2020) 41:1810–7. 10.1093/eurheart/ehaa373 - DOI - PMC - PubMed

Publication types

Actions

Grants and funding

WT_/Wellcome Trust/United Kingdom

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations
Miscellaneous
- NCI CPTAC Assay Portal

[1] Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. (2020) 181:271–80. 10.1016/j.cell.2020.02.052 - DOI - PMC - PubMed

[2] Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. (2020) 181:271–80. 10.1016/j.cell.2020.02.052 - DOI - PMC - PubMed

[3] Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. (2020) 367:1444–8. 10.1126/science.abb2762 - DOI - PMC - PubMed

[4] Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. (2020) 367:1444–8. 10.1126/science.abb2762 - DOI - PMC - PubMed

[5] Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W, et al. . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. (2020) 579:270–3. 10.1038/s41586-020-2012-7 - DOI - PMC - PubMed

[6] Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W, et al. . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. (2020) 579:270–3. 10.1038/s41586-020-2012-7 - DOI - PMC - PubMed

[7] Cheng H, Wang Y, Wang G. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. J Med Microbiol. (2020) 2020:1–5. 10.1002/jmv.25785 - DOI - PMC - PubMed

[8] Cheng H, Wang Y, Wang G. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. J Med Microbiol. (2020) 2020:1–5. 10.1002/jmv.25785 - DOI - PMC - PubMed

[9] Sama I, Ravera A, Santema B, Goor H, Maaten J, Cleland J, et al. . Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. (2020) 41:1810–7. 10.1093/eurheart/ehaa373 - DOI - PMC - PubMed

[10] Sama I, Ravera A, Santema B, Goor H, Maaten J, Cleland J, et al. . Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. (2020) 41:1810–7. 10.1093/eurheart/ehaa373 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Affiliations

Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Authors

Affiliations

Comment on

Similar articles

Cited by

References

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous